Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell-Derived Hepatocytes for Cell-Based Therapy. (2019)

First Author: Blackford SJI
Attributed to:  Manipulation of niche signals to advance cell therapies for liver disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/sctm.18-0084

PubMed Identifier: 30456803

Publication URI: http://europepmc.org/abstract/MED/30456803

Type: Journal Article/Review

Volume: 8

Parent Publication: Stem cells translational medicine

Issue: 2

ISSN: 2157-6564